The Fourth Left Atrial Appendage Occlusion Study
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Hamilton Health Sciences Corporation
- Study ID
- NCT05963698
- Status
- Recruiting
Conditions
- Atrial Fibrillation
- Stroke, Ischemic
- Systemic Embolism
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- WATCHMAN device — DEVICEParticipants will undergo endovascular left atrial appendage occlusion with the WATCHMAN device
Study Details
LAAOS-4 aims to determine if catheter-based endovascular left atrial appendage occlusion prevents ischemic stroke or systemic embolism in participants with atrial fibrillation, who remain at high risk of stroke, despite receiving ongoing treatment with oral anticoagulation.
Key Dates
- Start date
- Nov 30, 2023
- Status verified
- Jun 2026
- Primary completion
- Sep 1, 2029
- Completion
- Dec 1, 2029
Study Design
- Enrollment
- 4,000 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: WATCHMAN deviceParticipants will undergo endovascular left atrial appendage occlusion with the WATCHMAN device
- No Intervention: Standard CareParticipants will receive local, standard medical care
Primary Outcome Measure
Ischemic stroke or systemic embolism [ Time Frame: The study duration is event-driven. The primary analysis will be performed through study completion, once 265 primary efficacy endpoint events have occurred (an estimated average follow-up of 4 years). ]
Central Contacts
- Program Director905-521-2100
Locations (51)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Affinity Hospital dba Grandview Medical Center | Birmingham | Alabama | 35243 | - |
| Arrhythmia Research Group | Jonesboro | Arkansas | 72401 | Devi Nair, MD (PRINCIPAL_INVESTIGATOR) |
| Memorial Health Services | Fountain Valley | California | 92708 | Nikhil Warrier, MD (PRINCIPAL_INVESTIGATOR) |
| Loma Linda University Health | Loma Linda | California | 92354 | Rahul Bhardwaj, MD (PRINCIPAL_INVESTIGATOR) |
| Southern California Permanente Medical Group | Pasadena | California | 91101 | Bahram Khadivi, MD (PRINCIPAL_INVESTIGATOR) |
| Sutter Valley Hospitals dba Sutter Institute for Medical Research | Sacramento | California | 95816 | David Roberts, MD (PRINCIPAL_INVESTIGATOR) |
| JFK Medical Center Limited Partnership d/b/a HCA Florida JFK Hospital | Atlantis | Florida | 33462 | Marcelo Jimenez, MD (PRINCIPAL_INVESTIGATOR) |
| St. Vincent's Health System | Jacksonville | Florida | 32204 | Saumil Oza, MD (PRINCIPAL_INVESTIGATOR) |
| Largo Medical Center, Inc. d/b/a HCA Florida Largo Medical Center | Largo | Florida | 33770 | Jesse Klein, MD (PRINCIPAL_INVESTIGATOR) |
| HCA Florida Ocala Hospital | Ocala | Florida | 34471 | Gregory Von Mering, MD (PRINCIPAL_INVESTIGATOR) |
| The University of South Florida | Tampa | Florida | 33620 | Bibhu Mohanty, MD (PRINCIPAL_INVESTIGATOR) |
| Emory University | Atlanta | Georgia | 30322 | David De Lurgio, MD (PRINCIPAL_INVESTIGATOR) |
| St Luke's Regional Medical Center, Ltd | Boise | Idaho | 83712 | Marcos Daccarett, MD (PRINCIPAL_INVESTIGATOR) |
| Kootenai Health Inc. | Coeur d'Alene | Idaho | 83814 | Michele Murphy-Cook, MD (PRINCIPAL_INVESTIGATOR) |
| Northwestern University | Evanston | Illinois | 60208 | Albert Lin, MD (PRINCIPAL_INVESTIGATOR) |
| Cardiovascular Medicine, PLLC and Unity Point Trinity Rock Island | Rock Island | Illinois | 61201 | Mark Shen, MD (PRINCIPAL_INVESTIGATOR) |
| Community Health Network Inc. | Indianapolis | Indiana | 46256 | Krishna Malineni, MD (PRINCIPAL_INVESTIGATOR) |
| MercyOne Iowa Heart Center | West Des Moines | Iowa | 50266 | Pitayadet Jumrussirikul, MD (PRINCIPAL_INVESTIGATOR) |
| University of Kansas Medical Center Research Institute, Inc. | Kansas City | Kansas | 66160 | Madhu Reddy, MD (PRINCIPAL_INVESTIGATOR) |
| Babtist Health Lexington | Lexington | Kentucky | 40503 | Gery Tomassoni, MD (PRINCIPAL_INVESTIGATOR) |
| Ochsner Clinic Foundation | New Orleans | Louisiana | 70121 | Richard Zweifler, MD (PRINCIPAL_INVESTIGATOR) |
| University of Maryland Baltimore | Baltimore | Maryland | 21201 | Seemant Chaturvedi, MD (PRINCIPAL_INVESTIGATOR) |
| Lahey Clinic Inc. | Burlington | Massachusetts | 01805 | Bruce Hook, MD (PRINCIPAL_INVESTIGATOR) |
| University of Michigan | Ann Arbor | Michigan | 48109 | Hakan Oral, MD (PRINCIPAL_INVESTIGATOR) |
| Henry Ford Health System | Detroit | Michigan | 48202 | Waddah Maskoun, MD (PRINCIPAL_INVESTIGATOR) |
| Henry Ford Health System | Detroit | Michigan | 48202 | Amir Kaki, MD (PRINCIPAL_INVESTIGATOR) |
| Mayo Clinic | Rochester | Minnesota | 55905 | Eugene L. Scharf, MD (PRINCIPAL_INVESTIGATOR) |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | Taya Glotzer, MD (PRINCIPAL_INVESTIGATOR) |
| Presbyterian Healthcare Services d.b.a. Presbyterian Heart Group | Albuquerque | New Mexico | 87106 | Sharif Halim, MD (PRINCIPAL_INVESTIGATOR) |
| The Feinstein Institutes for Medical Research | Manhasset | New York | 11030 | Jeffrey Katz, MD (PRINCIPAL_INVESTIGATOR) |
| Cornell University for and on behalf of its Joan & Sanford I. Weill Medical College and The New York Presbyterian Hospital | New York | New York | 10065 | Christopher Liu, MD (PRINCIPAL_INVESTIGATOR) |
| NYU Grossman School of Medicine | New York | New York | 10065 | - |
| Mission Hospital HCA | Asheville | North Carolina | 28801 | John Rhyner, MD (PRINCIPAL_INVESTIGATOR) |
| Aultman Hospital | Canton | Ohio | 44710 | Firas Hamdan, MD (PRINCIPAL_INVESTIGATOR) |
| TriHealth Inc. | Cincinnati | Ohio | 45202 | Gaurang Gandhi, MD (PRINCIPAL_INVESTIGATOR) |
| University of Cincinnati | Cincinnati | Ohio | 45221 | Srinivas Rajsheker, MD (PRINCIPAL_INVESTIGATOR) |
| Cleveland Clinic | Cleveland | Ohio | 44195 | Oussama Wazni, MD (PRINCIPAL_INVESTIGATOR) |
| Saint Francis Hospital | Tulsa | Oklahoma | 74136 | Tom Hu, MD (PRINCIPAL_INVESTIGATOR) |
| The Pennsylvania State University and The Milton S. Hershey Medical Center | Hershey | Pennsylvania | 17033 | Soraya Samii, MD (PRINCIPAL_INVESTIGATOR) |
| The Trustees of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | Steven Messe, MD (PRINCIPAL_INVESTIGATOR) |
| University of Pittsburgh Medical Center (UPMC) Presbyterian Heart and Vascular Institute | Pittsburgh | Pennsylvania | 15213 | Sandeep Jain, MD (PRINCIPAL_INVESTIGATOR) |
| Rhode Island Hospital | Providence | Rhode Island | 02903 | Ana-Lucia Garcia-Guarniz, MD (PRINCIPAL_INVESTIGATOR) |
| Glanecare, Inc. d/b/a HCA Florida Brandon Hospital | Brentwood | Tennessee | 37027 | Umesh Gowda, MD (PRINCIPAL_INVESTIGATOR) |
| The University of Tennessee | Memphis | Tennessee | 38163 | Balaji Krishnaiah, MD (PRINCIPAL_INVESTIGATOR) |
| Texas Cardiac Arrhythmia Research Foundation | Austin | Texas | 78705 | - |
| Baylor Research Institute | Dallas | Texas | 75204 | Praveen Rao, MD (PRINCIPAL_INVESTIGATOR) |
| Heart Rhythm Associates | The Woodlands | Texas | 77380 | - |
| CHRISTUS Northeast Texas Health System | Tyler | Texas | 75701-2263 | Stanislav Weiner, MD (PRINCIPAL_INVESTIGATOR) |
| The Rector and Visitors of the University of Virginia | Charlottesville | Virginia | 22903 | Rohit Malhotra, MD (PRINCIPAL_INVESTIGATOR) |
| CommonSpirit Health Research Institute | Tacoma | Washington | 98405 | Nasir Shariff, MD (PRINCIPAL_INVESTIGATOR) |
| The Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | James Oujiri, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Birmingham, AL
By condition
By specialty
By research site
Affinity Hospital dba Grandview Medical Center· Birmingham, ALArrhythmia Research Group· Jonesboro, ARMemorial Health Services· Fountain Valley, CALoma Linda University Health· Loma Linda, CASouthern California Permanente Medical Group· Pasadena, CASutter Valley Hospitals dba Sutter Institute for Medical Research· Sacramento, CA
Related Studies
- Identification of Genomic Predictors of Adverse Events After Cardiac SurgeryRecruiting · Brigham and Women's Hospital · Boston, Massachusetts
- Minocycline Plus Amiodarone Versus Amiodarone Alone for the Prevention of Atrial Fibrillation After Cardiac SurgeryPHASE2 · Not Yet Recruiting · Baystate Medical Center · Melrose, Massachusetts
- Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial FibrillationPHASE4 · Recruiting · University of Illinois at Chicago · Chicago, Illinois
- Chloroquine for Patients With Symptomatic Persistent Atrial Fibrillation: A Prospective Pilot StudyPHASE2 · Recruiting · University of South Florida · Tampa, Florida